Search research articles
Contact Us
Filters
Showing results (131-140 of 210) with videos related to
Page
of 21
Sort By:
Urology
|
September 23, 2015
Occult High-risk Disease in Clinically Low-risk Prostate Cancer with ≥50% Positive Biopsy Cores: Should National Guidelines Stop Calling Them Low Risk?
Kathryn T Dinh, Vinayak Muralidhar, Brandon A Mahal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 6, 2019
Comparing the Association Between Insurance and Mortality in Ovarian, Pancreatic, Lung, Colorectal, Prostate, and Breast Cancers
Alexander P Cole, Chang Lu, Marieke J Krimphove, et al.
Advances in Radiation Oncology
|
April 16, 2020
Prostate Cancer Radiation Therapy Recommendations in Response to COVID-19
Nicholas G Zaorsky, James B Yu, Sean M McBride, et al.
Cancer
|
January 12, 2019
Impact of tumor, treatment, and access on outcomes in bladder cancer: Can equal access overcome race-based differences in survival?
Alexander P Cole, Sean A Fletcher, Sebastian Berg, et al.
Advances in Radiation Oncology
|
November 4, 2020
Prostate Cancer Radiation Therapy Recommendations in Response to COVID-19
Nicholas G Zaorsky, James B Yu, Sean M McBride, et al.
Clinical Genitourinary Cancer
|
December 3, 2017
Pathologic Outcomes of Gleason 6 Favorable Intermediate-Risk Prostate Cancer Treated With Radical Prostatectomy: Implications for Active Surveillance
David D Yang, Brandon A Mahal, Vinayak Muralidhar, et al.
Cancer
|
May 19, 2025
Disparities in receipt of palliative-intent treatment among disaggregated Hispanic populations with breast, lung, and prostate cancer in the United States
Shriya K Garg, Khushi Kohli, Isha K Garg, et al.
Cancer
|
August 24, 2017
Receipt of definitive therapy in elderly patients with unfavorable-risk prostate cancer
David D Yang, Brandon A Mahal, Vinayak Muralidhar, et al.
The Journal of Urology
|
November 12, 2018
Quality of Care in the Treatment of Localized Intermediate and High Risk Prostate Cancer at Minority Serving Hospitals
Marieke J Krimphove, Sean A Fletcher, Alexander P Cole, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 19, 2018
The Impact of Radiation Therapy on Lymphocyte Count and Survival in Metastatic Cancer Patients Receiving PD-1 Immune Checkpoint Inhibitors
Luke R G Pike, Andrew Bang, Brandon A Mahal, et al.
Page
of 21
Search research articles
Search
Showing results (131-140 of 210) with videos related to
Sort By:
Page
of 21
Urology
|
September 23, 2015
Occult High-risk Disease in Clinically Low-risk Prostate Cancer with ≥50% Positive Biopsy Cores: Should National Guidelines Stop Calling Them Low Risk?
Kathryn T Dinh, Vinayak Muralidhar, Brandon A Mahal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 6, 2019
Comparing the Association Between Insurance and Mortality in Ovarian, Pancreatic, Lung, Colorectal, Prostate, and Breast Cancers
Alexander P Cole, Chang Lu, Marieke J Krimphove, et al.
Advances in Radiation Oncology
|
April 16, 2020
Prostate Cancer Radiation Therapy Recommendations in Response to COVID-19
Nicholas G Zaorsky, James B Yu, Sean M McBride, et al.
Cancer
|
January 12, 2019
Impact of tumor, treatment, and access on outcomes in bladder cancer: Can equal access overcome race-based differences in survival?
Alexander P Cole, Sean A Fletcher, Sebastian Berg, et al.
Advances in Radiation Oncology
|
November 4, 2020
Prostate Cancer Radiation Therapy Recommendations in Response to COVID-19
Nicholas G Zaorsky, James B Yu, Sean M McBride, et al.
Clinical Genitourinary Cancer
|
December 3, 2017
Pathologic Outcomes of Gleason 6 Favorable Intermediate-Risk Prostate Cancer Treated With Radical Prostatectomy: Implications for Active Surveillance
David D Yang, Brandon A Mahal, Vinayak Muralidhar, et al.
Cancer
|
May 19, 2025
Disparities in receipt of palliative-intent treatment among disaggregated Hispanic populations with breast, lung, and prostate cancer in the United States
Shriya K Garg, Khushi Kohli, Isha K Garg, et al.
Cancer
|
August 24, 2017
Receipt of definitive therapy in elderly patients with unfavorable-risk prostate cancer
David D Yang, Brandon A Mahal, Vinayak Muralidhar, et al.
The Journal of Urology
|
November 12, 2018
Quality of Care in the Treatment of Localized Intermediate and High Risk Prostate Cancer at Minority Serving Hospitals
Marieke J Krimphove, Sean A Fletcher, Alexander P Cole, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 19, 2018
The Impact of Radiation Therapy on Lymphocyte Count and Survival in Metastatic Cancer Patients Receiving PD-1 Immune Checkpoint Inhibitors
Luke R G Pike, Andrew Bang, Brandon A Mahal, et al.
Page
of 21